Suspension for s / c administration 1 dose
hemagglutinin of viral strains
influenza A (H 1 N 1 ) 10 В± 1 Ојg
influenza A (H 3 N 2 ) 10 В± 1 Ојg
influenza B serotype 13 В± 1 Ојg
Auxiliary substances: albumin rr d / inf. 10% and 20%, thiomersal 50 В± 7.5 Ојg.
0.5 ml - ampoules (5) - packings of cellular contour (2) - packs cardboard.
0.5 ml - ampoules (10) - cardboard boxes.
0.5 ml - syringes (1) - packings of cellular contour (1) - packs cardboard.
INSTRUCTION FOR THE SPECIALIST.
Description of the drug approved by the manufacturer for the printed edition of 2013.
The vaccine causes the formation of specific immunity against the influenza virus types A and B. Protective effect
The vaccine, as a rule, comes in 3 weeks after vaccination and lasts 10-12 months.
- Prevention of influenza in adults over 18 years.
Vaccinations are carried out in the autumn-winter period.
Annual vaccination is recommended first of all for people with a high risk of complications and people who are at a high risk of getting the flu or getting infected by others:
- persons over 60 years of age;
- Persons suffering from chronic physical illnesses;
- often ill acute respiratory infections;
- medical workers;
- workers in the service sector, transport, educational institutions.
The vaccine is administered once, subcutaneously, at a dose of 0.5 ml, to the area of вЂ‹вЂ‹the outer surface of the shoulder a few centimeters below the shoulder joint.
Before using the ampoule with the drug should be shaken carefully.
The preparation is not suitable for use in ampoules with broken integrity or marking, with changing physical properties (color, transparency, homogeneity), expired shelf life, improper storage.
Opening of ampoules and the vaccination procedure are carried out with strict adherence to aseptic and antiseptic rules.
The drug in the opened ampoule is not subject to storage.
The vaccination is recorded in the prescribed registration forms with the date of administration of the drug, dose, serial number and name of the manufacturer.
With the introduction of the drug, some of the vaccinated patients may experience general reactions in the form of malaise, headache, and fever. Not more than 3% of reactions over 37.5 В° РЎ (including no more than 0.5% over 38.5 В° РЎ), registered in the first two days after immunization, with a duration not exceeding three days are allowed.
Local reactions (hyperemia and puffiness) occur in most of the vaccinated; a limited number of infiltrates can form in a part of the vaccinated. The development of an infiltrate up to 50 mm is allowed in no more than 3%. The duration of local reactions does not exceed 5 days.
- allergic reactions to chicken eggs and hypersensitivity to chicken protein;
- a response or post-vaccination complication to previous administration of seasonal influenza vaccines;
- acute infectious and non-infectious diseases, chronic diseases at the stage of exacerbation - vaccinations are carried out not earlier than a month after recovery (remission). For non-severe acute respiratory viral infections, acute intestinal diseases, vaccination is carried out after normalizing the temperature;
- systemic diffuse diseases of connective tissue;
- adrenal gland diseases;
- hereditary, degenerative and progredient diseases of the nervous system;
- Pregnancy and lactation.
The possibility of vaccination of persons suffering from chronic diseases not listed in the list of contraindications is determined by the attending physician based on the patient's condition.
PREGNANCY AND LACTATION
Contraindicated in pregnancy, during lactation.
APPLICATION FOR CHILDREN
Applied in adults over 18 years of age
APPLICATION IN ELDERLY PATIENTS
Annual vaccination is recommended primarily to people with a high risk of complications and people who are at a high risk of influenza infection or other people, for example, people over 60 years of age.
Precautions for use
All persons subject to inoculations should be examined by a doctor taking into account anamnestic data. On the day of vaccination
vaccinated should be examined by a doctor with mandatory thermometry. At a temperature above 37 В° C vaccination is not carried out. The doctor is responsible for the correct administration of the vaccine.
After vaccination, the vaccinated should be under medical supervision for at least 30 minutes. Place of vaccination should be provided with anti-shock therapy.
Information about the possible effect of the drug on the ability to drive vehicles, mechanisms.
Cases of overdose are not established.
The flu vaccine can be used concomitantly with other vaccines of the National Schedule of Prophylactic Inoculations and inactivated vaccines of the preventive vaccination calendar for epidemic indications administered by an adult. This should take into account contraindications to each of the vaccines used, the drugs must be injected into different parts of the body with different syringes.
TERMS OF RELEASE FROM PHARMACY
For treatment and prevention institutions. Allowed to leave a prescription vaccine in disposable syringes.
TERMS AND CONDITIONS OF STORAGE
Store in accordance with SP 126.96.36.1998-03 at a temperature of 2 to 8 В° C in a place inaccessible to children. Freezing is not allowed. Shelf life - 1 year.
The information is provided for your information, do not self-medicate, it is dangerous for your health.